2022 annual financial data
Apogee Therapeutics 2022 Operating margin
Apogee Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -30,727,000 USD and net income was -39,785,000 USD.
Operating cash flow was -16,427,000 USD.
Get free Apogee Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -30,727,000 USD
- Net income
- -39,785,000 USD
- Operating cash flow
- -16,427,000 USD